- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06208085
Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development
An Avocado Intervention to Increase the Nutrients in Human Milk in Support of Infant Cognitive Development
The goal of this interventional study is to establish a whole food, avocado, as a viable study material to supplement mothers and infants with nutrients that support optimal brain development. Eighty-eight breastfeeding dyads, 3m postnatal, will participate in this study designed to:
- To document whether lactating mothers will comply in the consumption of 5 avocados a week for 12 weeks.
- To ascertain the choline, lutein, and fatty acids present in human milk in women who eat avocado.
- To measure the cognitive advantage conferred to infants whose mothers consume avocados while breastfeeding compared to a non-avocado-eating reference group.
To this end, healthy, lactating women who are 13 weeks postpartum and their infants will be enrolled. Mothers will be provided avocados on a bi-weekly basis and will be asked to consume an avocado a day. Infant cognition will be tested when the infants are 4.5 and 6 months of age. Milk samples and diet data will be collected and assayed on a bi-weekly basis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Nutrients do not appear in nature alone with some appearing together more often than not. It is reasonable to posit that nutrients are working together, and thus, the synergies among the nutrients are important to understand. First, choline is integral to brain fatty acids in that phosphatidylcholine (PC) serves an active role in mediating hepatic export of fatty acids to extra-hepatic tissues such as brain: fatty acids are stored in the liver, and PC moves them to the brain. Erythrocyte PC-DHA is integral to our consideration of a potential mechanism behind our results. Enriched in docosahexaenoic acid (DHA), PC comprises the cell membrane and influences membrane fluidity with downstream effects on signal transduction thereby improving speed of processing and recognition memory. Lutein has a very important role also in that it is known to co-localize with DHA specifically resulting in improvements in visual acuity, for example, and in general, it has been shown to protect fatty acids from peroxidation. Indeed, interventions with avocado have shown a significant increase in plasma lutein and a decrease in lipid peroxidation. It is hypothesized that lutein is also having this effect in the brain. As work with single nutrient supplementation does not yield strong cognitive effects, the investigators study the effects of co-occurring nutrients on cognitive development. The proposed study is designed to achieve an overall objective of establishing a whole food, avocado, as a viable study material in the pursuit of optimization of human milk with nutrients that support brain development. The long-term goal is to establish guidelines for maternal nutrition during gestation and lactation that include key nutrients for fetal and infant brain development, and the overall impact of this research program will be to set children on a trajectory for school readiness. The central hypothesis is that maternal avocado consumption will provide nutrients through human milk to support the development and function of neural substrates that support cognition. Specifically, choline, lutein, and fatty acids will work synergistically to improve brain function.
Mothers will be randomized to avocado or no avocado (due to lack of an appropriate control food). Participants will come to the lab 3 times across 6 months (enrollment/3months, 4.5 months, and 6 months). Milk sample will be provided every two weeks and will be picked up from the participants. At pickup, the avocado group will also be provided a new supply of avocados. Diet data will be collected at each visit/pickup (every two weeks). The infant will complete a recognition memory test using electrophysiology at 6 months as well as the Bayley Scales of Infant Development at 4.5 months. The mother will complete a temperament questionnaire at 3 and 6 months. Saliva samples will also be collected.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Study Coordinator
- Phone Number: 704-250-5018
- Email: feedingbrains@unc.edu
Study Contact Backup
- Name: Carol L Cheatham, Ph.D.
- Phone Number: 704-250-5010
- Email: carol_cheatham@unc.edu
Study Locations
-
-
North Carolina
-
Kannapolis, North Carolina, United States, 28081
- Recruiting
- Nutrition Research Institute
-
Contact:
- Brandi Childers
- Phone Number: 704-250-5005
- Email: brandi_childers@unc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Healthy lactating women at 13 weeks postpartum
- Planning to exclusively breastfeed to 6 months of age
- Gave birth at 38 weeks or greater gestation without remarkable incident
- Pre-pregnancy BMI <30
Exclusion Criteria
- Gestational diabetes
- Infant with diagnosis or documented suspicion of developmental delay
- Any documented seizure activity in infant
- Family history of avocado, latex, or banana allergies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Avocado
Participants will be provided avocados and asked to consume an avocado a day for 12 weeks.
|
Intervention arm
|
|
No Intervention: No Avocado
Comparison arm in which no intervention occurs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recognition Memory in an Oddball Task
Time Frame: Week 12 (at 6 months of age)
|
The difference in microvolts between the negative deflection to novel pictures and the negative deflection to familiar pictures at approximately 100-400ms after the pictures come on the screen will be measured in an event-related potentials (ERP) paradigm.
The investigators hypothesize that the avocado group will have better memory for the familiar pictures than the no avocado group.
|
Week 12 (at 6 months of age)
|
|
Change in Choline Content of Milk
Time Frame: Baseline, Week 12
|
Human milk will be assayed for choline every two weeks and analyzed for change over time (7 data points across 12 weeks).
|
Baseline, Week 12
|
|
Change in Lutein Content of Milk
Time Frame: Baseline, Week 12
|
Human milk will be assayed for lutein every two weeks and analyzed for change over time (7 data points across 12 weeks).
|
Baseline, Week 12
|
|
Change in Fatty Acid Content of Milk
Time Frame: Baseline, Week 12
|
Human milk will be assayed for fatty acids every two weeks and analyzed for change over time (7 data points across 12 weeks).
|
Baseline, Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bayley Scales of Infant Development (BSID)
Time Frame: Week 6 (at 4.5 months of age)
|
Neurodevelopmental assessment scores are age dependent and based motor and behavioral abilities, often reported for normal or abnormal for age.
Bayley Scales of Infant and Toddler Development, 3rd edition, (Bayley III) is an instrument designed to measure the developmental functioning of infants and toddlers between the ages of 1 month and 42 months (age adjustments for prematurity are accommodated with the tool).
It provides age specific composite scores for cognitive (91 items, score min 55 max 145), language (98 items, score min 47 max 153), and motor (138 items, score min 46 max 154) skills.
For all scales, higher scores are better and lower scores indicate possible delay/deficit.
|
Week 6 (at 4.5 months of age)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Carol L Cheatham, Ph.D., University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-2933
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breastfeeding, Exclusive
-
Halic UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
University of Ontario Institute of TechnologyDurham Region Health DepartmentUnknown
-
University of California, DavisUniversity of California, San Francisco; Public Hospital Roatan, HondurasCompletedBreastfeeding | Breastfeeding, ExclusiveHonduras
-
Jimma UniversityNestlé FoundationCompletedBreastfeeding | Breastfeeding, Exclusive | Breast Feeding, Exclusive | Breast Fed | BreastfedEthiopia
-
Celal Bayar UniversityManisa Celal Bayar UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
Benten Technologies, Inc.National Institute on Minority Health and Health Disparities (NIMHD); George... and other collaboratorsEnrolling by invitationBreastfeeding | Exclusive BreastfeedingUnited States
-
The University of Hong KongCompletedBreastfeeding | Breastfeeding, ExclusiveHong Kong
-
Albert Einstein College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedBreastfeeding | Breastfeeding, ExclusiveUnited States
-
Women and Infants Hospital of Rhode IslandCompletedBreastfeeding, ExclusiveUnited States
-
University of California, DavisAcademic Pediatric AssociationCompletedBreastfeeding, ExclusiveUnited States
Clinical Trials on Avocado
-
University of California, Los AngelesHass Avocado BoardCompleted
-
Clinical Nutrition Research Center, Illinois Institute...Hass Avocado BoardCompleted
-
University of AdelaideCommonwealth Scientific and Industrial Research Organisation, Australia; Isagenix... and other collaboratorsCompleted
-
Loma Linda UniversityHass Avocado BoardCompletedGlycemic Index | Insulin | Satiety | Gastrointestinal Peptides and HormonesUnited States
-
Midwest Center for Metabolic and Cardiovascular...Hass Avocado BoardNot yet recruitingOverweight (BMI > 25) | Hs-CRP | Obesity (BMI>30)United States
-
University of Illinois at Urbana-ChampaignHass Avocado BoardUnknownInsulin Resistance | Insulin Sensitivity | Obesity, AbdominalUnited States
-
Arizona State UniversityRecruitingGut Microbiome | Infant Growth | Neurocognitive Correlates of Eating HabitsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliRecruitingBreast Cancer Females | Telomere LengthSpain
-
Wake Forest University Health SciencesCompletedCardiovascular Diseases | Diabetes | Metabolic Syndrome | Liver Fat | Cardiovascular Risk Factor | Diet Habit | Dietary Modification | High Cholesterol | Triglycerides High | Low-density-lipoprotein-type | HDL Cholesterol, Low Serum | High Blood Sugar | Intra-abdominal Fat | High Density Lipoprotein DeficiencyUnited States
-
Penn State UniversityHass Avocado BoardCompletedCardiovascular Disease | HyperlipidemiaUnited States